|Videos|March 22, 2022
PharmExec CEO Roundtable: Hybrid Interactions
In this segment, executives discuss the need to adjust to virtual and in-person, face-to-face interactions with both internal and external stakeholders.
Advertisement
Please read the
Newsletter
Lead with insight with the Pharmaceutical Executive newsletter, featuring strategic analysis, leadership trends, and market intelligence for biopharma decision-makers.
Advertisement
Related Content
Advertisement
Advertisement
Advertisement
Trending on PharmExec
1
Pharmaceutical Executive Daily: Shah Capital's Plan to Vote Against Novavax Board Nominees
2
Lipid Lowering with PCSK9 Inhibition: Long-Term Efficacy, Long-Standing Barriers
3
Q&A: Supply Chain Fallout From Iran War, Tariff Uncertainty
4
Roche and C4 Therapeutics Expands Partnership with $1 Billion Collaboration Agreement
5